GSK vs OTEX · P/E 13, $103.31B cap vs P/E 12, rev $5.25B
GlaxoSmithKline PLC ADR (GSK) versus Open Text Corp (OTEX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Open Text Corp (OTEX) is a software - application company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported OTEX revenue for 2026-06-30 was $5.25B. Net income was $643.0M. Revenue was up 1.5% from 2025-06-30 to 2026-06-30. OTEX currently screens at market cap $7.66B and trailing P/E 12.0.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. OTEX currently screens at market cap $7.66B and trailing P/E 12.0.
Not investment advice. Open the GSK and OTEX stock pages for the full models.
Not investment advice.